SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 91 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $621,000 | -48.2% | 52,654 | -53.9% | 0.09% | -35.9% |
Q2 2017 | $1,200,000 | -22.0% | 114,330 | -18.2% | 0.14% | -6.0% |
Q1 2017 | $1,538,000 | -31.2% | 139,845 | -15.3% | 0.15% | -19.3% |
Q4 2016 | $2,237,000 | -19.4% | 165,088 | -26.8% | 0.19% | -29.4% |
Q3 2016 | $2,775,000 | +41.7% | 225,464 | +26.3% | 0.26% | -1.5% |
Q2 2016 | $1,959,000 | +192.4% | 178,582 | +191.5% | 0.27% | +192.4% |
Q1 2016 | $670,000 | -37.4% | 61,272 | -1.0% | 0.09% | -32.4% |
Q4 2015 | $1,070,000 | +175.1% | 61,877 | +216.2% | 0.14% | +123.0% |
Q3 2015 | $389,000 | -58.4% | 19,570 | -67.4% | 0.06% | -49.2% |
Q1 2015 | $934,000 | -36.5% | 60,050 | -41.7% | 0.12% | -42.3% |
Q4 2014 | $1,471,000 | +134.6% | 103,007 | +6.7% | 0.21% | +101.9% |
Q3 2014 | $627,000 | +69.9% | 96,507 | +80.7% | 0.10% | +51.5% |
Q2 2014 | $369,000 | +108.5% | 53,407 | +115.3% | 0.07% | +28.3% |
Q1 2014 | $177,000 | – | 24,807 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 2,819,708 | $29,607,000 | 8.99% |
Rubric Capital Management LP | 577,900 | $6,068,000 | 1.25% |
Malaga Cove Capital, LLC | 84,241 | $882,000 | 0.53% |
NEA Management Company, LLC | 1,258,507 | $13,214,000 | 0.48% |
CLARK ESTATES INC/NY | 250,000 | $2,625,000 | 0.45% |
AlphaMark Advisors, LLC | 98,400 | $1,033,000 | 0.44% |
Ativo Capital Management LLC | 138,032 | $1,449,000 | 0.40% |
TFS CAPITAL LLC | 83,694 | $879,000 | 0.34% |
GLOBEFLEX CAPITAL L P | 103,949 | $1,091,000 | 0.27% |
Bowling Portfolio Management LLC | 135,021 | $1,418,000 | 0.21% |